Category Archives: Cell Therapy

Public release date: 6-Nov-2012 [ | E-mail | Share ] Contact: Jill Scoggins jill.scoggins@louisville.edu 502-852-7461 University of Louisville LOS ANGELES Marked sustained improvement in all patients with zero adverse effects. For a phase I clinical trial, these results are the Holy Grail. Yet researchers from the University of Louisville and Brigham and Women's Hospital today reported just such almost-never-attained data. In a Late-Breaking Clinical Trial session at the American Heart Association Scientific Sessions 2012 meeting, Roberto Bolli, M.D., of the University of Louisville and Piero Anversa, M.D., of Brigham and Women's Hospital, Boston, presented data from their groundbreaking research in the use of autologous adult stem cells with patients who had previous heart attacks. They report that after two years, all patients receiving the stem cell therapy show improvement in heart function, with an overall 12.9 absolute unit increase in left ventricular ejection fraction (LVEF), a standard measure of heart function that shows the amount of blood ejected from the left ventricle during a heartbeat. No adverse effects resulting from the therapy were seen. Moreover, MRIs performed on nine patients in the trial showed evidence of myocardial regeneration new heart tissue replacing former dead tissue killed by heart attack. "The … Continue reading →

Public release date: 6-Nov-2012 [ | E-mail | Share ] Contact: Steve Goodyear sgoodyear@mhif.org 952-807-8365 Minneapolis Heart Institute Foundation MINNEAPOLIS, MN November 6, 2012 Administering autologous stem cells obtained from bone marrow either 3 or 7 days following a heart attack did not improve heart function six months later, reports a new clinical trial supported by the National Institutes of Health. The results of this trial, called TIME (Transplantation In Myocardial Infarction Evaluation), were presented by Jay Traverse, MD of the Minneapolis Heart Institute Foundation Tuesday, Nov. 6, at the 2012 Scientific Sessions of the American Heart Association in Los Angeles. The results of this trial mirror a previous, related study (LateTIME) which found that autologous bone marrow stem cell therapy given 2-3 weeks after a heart attack did not improve cardiac recovery. Both TIME and LateTIME were carried out by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute. "The data presented by TIME do much to advance stem cell therapy research," said Jay Traverse, MD of the Minneapolis Heart Institute Foundation and Principal Investigator of this study. "While this study did not provide a demonstrated cardiac benefit after six months, … Continue reading →

Public release date: 6-Nov-2012 [ | E-mail | Share ] Contact: Steve Goodyear sgoodyear@mhif.org 952-807-8365 Minneapolis Heart Institute Foundation MINNEAPOLIS, MN November 6, 2012 Administering autologous stem cells obtained from bone marrow either 3 or 7 days following a heart attack did not improve heart function six months later, reports a new clinical trial supported by the National Institutes of Health. The results of this trial, called TIME (Transplantation In Myocardial Infarction Evaluation), were presented by Jay Traverse, MD of the Minneapolis Heart Institute Foundation Tuesday, Nov. 6, at the 2012 Scientific Sessions of the American Heart Association in Los Angeles. The results of this trial mirror a previous, related study (LateTIME) which found that autologous bone marrow stem cell therapy given 2-3 weeks after a heart attack did not improve cardiac recovery. Both TIME and LateTIME were carried out by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute. "The data presented by TIME do much to advance stem cell therapy research," said Jay Traverse, MD of the Minneapolis Heart Institute Foundation and Principal Investigator of this study. "While this study did not provide a demonstrated cardiac benefit after six months, … Continue reading →

RIO DE JANEIRO--(BUSINESS WIRE)-- CryopraxisTM/CellPraxis aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013. The phase IIA/B clinical trial study was completed in December 2011. These trials involved the use of a proprietary autologous stem cell formulation (MonocellTM) indicated for neoangiogeneses. Safety and efficacy of this product was evaluated in patients with refractory angina, a no option disease condition, characterized by severe chest pain for which there is no efficient treatment available, says the President of both Companies, Eduardo Cruz. ReACT, MonocellTMs derived product, showed evidence of safety and efficacy in our initial clinical trials. All patients included in this trial were classified as Class IV Angina in CCSAC* (the most severe class of chest pain). In the first group of patients, whose data was published**, there was a progressive and sustained improvement in angina symptoms, with 87.5% of the patients completing the clinical trial with a CCSAC score of 0 or 1. Angina symptom relief began as early as 3 months post procedure with continuing improvement through the 18th month, suggesting that angiogenesis began early, and that it kept evolving 18 months after … Continue reading →

FAQ-11 of 19: Why Have Stem Cell Therapy in Thailand's Stem Cell Clinic? youtu.be A few gentle suggestions on why visiting the only European-licensed stem cell clinic in Thailand is a better choice for time, optimum results and budget. For more detailed answers about Thailand's one licensed stem cell clinic, visit bit.lyFrom:Harvey WallbangerViews:1 0ratingsTime:01:16More inNonprofits Activism Read more here: FAQ-11 of 19: Why Have Stem Cell Therapy in Thailand's Stem Cell Clinic? - Video … Continue reading →

FAQ-10 of 19: Do Stem Cells Cause Cancer In Stem Cell Therapy? youtu.be People ask us if stem cell therapy can CAUSE cancer, and they are wise to be wary, but stem cell therapy has been proving effective AGAINST cancer, and has not cause any known cases of cancer to-date. For more personalized information, visit StemCell-Asia.info now.From:Harvey WallbangerViews:0 0ratingsTime:01:06More inScience Technology See the original post: FAQ-10 of 19: Do Stem Cells Cause Cancer In Stem Cell Therapy? - Video … Continue reading →

FAQ-11 of 19: Why Have Stem Cell Therapy in Thailand's Stem Cell Clinic? youtu.be A few gentle suggestions on why visiting the only European-licensed stem cell clinic in Thailand is a better choice for time, optimum results and budget. For more detailed answers about Thailand's one licensed stem cell clinic, visit bit.lyFrom:Harvey WallbangerViews:1 0ratingsTime:01:16More inNonprofits Activism Read more here: FAQ-11 of 19: Why Have Stem Cell Therapy in Thailand's Stem Cell Clinic? - Video … Continue reading →

FAQ-12 of 19: Are Our Stem Cell Doctors Qualified for Stem Cell Therapy? youtu.be The straight answer to this question might surprise you, but only if you think stem cell therapy is something that was approved for certain patients THIS year. And for more surprising, encouraging details on stem cell therapies and your particular case, visit bit.ly today.From:Harvey WallbangerViews:0 0ratingsTime:00:55More inPeople Blogs Read the original here: FAQ-12 of 19: Are Our Stem Cell Doctors Qualified for Stem Cell Therapy? - Video … Continue reading →

FAQ-13 of 19: What Stem Cell Therapy Will Be MY Stem Cell Treatment? youtu.be This seeks to answer the'what do I need for ME?' question, although it is a personal question not readily answerable online, so for your questions, go to bit.lyFrom:Harvey WallbangerViews:1 0ratingsTime:01:28More inEducation Read the original: FAQ-13 of 19: What Stem Cell Therapy Will Be MY Stem Cell Treatment? - Video … Continue reading →

FAQ-14 of 19: Do We Offer a Guarantee for Our Stem Cell Therapy? youtu.be Yes, a reasonable guarantee is provided, and you can learn more of it in this video. When you want more than this, visit bit.ly for personalized details of how stem cell therapy can benefit you.From:Harvey WallbangerViews:0 0ratingsTime:01:15More inPeople Blogs Read more here: FAQ-14 of 19: Do We Offer a Guarantee for Our Stem Cell Therapy? - Video … Continue reading →